Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

INVO Fertility (IVF) EBIAT (2016 - 2025)

INVO Fertility (IVF) has disclosed EBIAT for 15 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • Quarterly EBIAT fell 62.18% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$29.0 million through Sep 2025, down 289.59% year-over-year, with the annual reading at -$9.1 million for FY2024, 13.7% down from the prior year.
  • EBIAT for Q3 2025 was -$2.6 million at INVO Fertility, up from -$5.3 million in the prior quarter.
  • The five-year high for EBIAT was $97018.0 in Q4 2021, with the low at -$17.4 million in Q1 2025.
  • Average EBIAT over 5 years is -$3.2 million, with a median of -$2.5 million recorded in 2021.
  • The sharpest move saw EBIAT skyrocketed 102.58% in 2021, then plummeted 2952.08% in 2022.
  • Over 5 years, EBIAT stood at $97018.0 in 2021, then tumbled by 2952.08% to -$2.8 million in 2022, then grew by 29.16% to -$2.0 million in 2023, then plummeted by 84.86% to -$3.6 million in 2024, then increased by 27.01% to -$2.6 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$2.6 million, -$5.3 million, and -$17.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.